David Schley

Dr David Schley was our Research Communications Manager up until 2019.

He has a PhD in mathematics from the University of Surrey. He is now Deputy Director at Sense about Science.

David is an experienced development specialist and is passionate about using research so that people with MS can make informed decisions about their future.

Blogs by David Schley

Exercise proven to help in MS

Research shows that exercise can improve many symptoms common in MS and improve wellbeing.

Rituximab shown to slow disability progression in secondary progressive MS

A new study suggests that some disease modifying therapies (DMTs) have the potential to benefit people with progressive forms of MS.

Managing MS pain - what does the research say?

Many people living with MS will experience pain as one of their symptoms. It can occur at any time, come from more than one source, or result from other symptoms, like spasticity or fatigue.

7 things you need to know about HSCT

Autologous haematopoietic stem cell transplantation (HSCT) is a recognised treatment for some forms of MS.

Behind the headlines: MSCT and MS

MSCT (or mesenchymal stem cell therapy) is an exciting new area of research being explored as an MS treatment. And it was featured in a Channel 4 documentary which followed lawyer Mark Lewis as he took part in an MSCT trial in Jerusalem.

Hopes for LIF – what’s the evidence?

Reports of a potential new approach to manipulating immune cells have popped up in the news. We look at how close it is to delivering a treatment for MS.